Results 11 to 20 of about 30,754 (261)

Aortic flow is abnormal in HFpEF [PDF]

Wellcome Open Research, 2023
Aims Turbulent aortic flow makes the cardiovascular system less effective. It remains unknown if patients with heart failure with preserved ejection fraction (HFpEF) have disturbed aortic flow. This study sought to investigate advanced markers of aortic flow disturbances in HFpEF.
Mehmood, Z., Assadi, H., Li, R., Kasmai, B., Matthews, G., Grafton-Clarke, C., Sanz-Cepero, A., Zhao, X., Zhong, L., Aung, N., Skinner, K., Hadinnapola, C., Swoboda, P., Swift, A.J., Vassiliou, V.S., Miller, C., van der Geest, R.J., Peterson, S., Garg, P.   +18 more
core   +10 more sources

Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program.

Journal of the American College of Cardiology
Inflammation is thought to be an important mechanism for the development and progression of obesity-related heart failure with preserved ejection fraction (HFpEF). In the STEP-HFpEF Program, once-weekly 2.4 mg semaglutide improved heart failure-related symptoms, physical limitations, and exercise function, reduced the levels of C-reactive protein (CRP),
Verma, Subodh, Petrie, Mark C, Borlaug, Barry A, Butler, Javed, Melanie D., Davies, Kitzman, Dalane W, Shah, Sanjiv J, Ronnback, Cecilia, Abildstrom, Steen Z, Liisberg, Karoline, Wolf, Dennis, von Lewinski, Dirk, Lelonek, Malgorzata, Melenovsky, Vojtech, Senni, Michele, Kosiborod, Mikhail N   +15 more
openaire   +5 more sources

Prognostic Utility of the HFpEF-ABA Score for HFpEF Patients

JACC: Advances
The HFpEF-ABA score, incorporating age, body mass index (BMI), and atrial fibrillation (AF), has demonstrated utility in patients with heart failure with preserved ejection fraction (HFpEF).This study evaluated the prognostic performance of the HFpEF-ABA score within the Americas and Russia/Georgia cohorts of the TOPCAT (Treatment of Preserved Cardiac ...
Wengen Zhu, Linjuan Guo, Xi Chen, Min Ye
openaire   +3 more sources

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study [PDF]

, 2021
Aims Heart failure with preserved ejection fraction (HFpEF) accounts for half of all heart failure (HF), but low awareness and diagnostic challenges hinder identification in primary care.
Schiff, Rebekah, Brimicombe, James, Gordon, B, Glover, V, Newark, C, Navazh Jalaludeen, Schiff, R, Chew-Graham, C, Fox, R, Blakeman, T, Wellwood, I, Jalaludeen, Navazh, Jonathan Mant, Edwards, D, Mant, J, Schramm, C, Blake, D, Taylor, Clare J.; id_orcid, Clare J. Taylor, Rutter, H, Deaton, Christi, Cheriyan, Joseph, Crawshaw, J, Brimicombe, J, Taffe, J, Jalaludeen, N, Ashdown, H, Duncan Edwards, Maclachlan, S, Borja-Boluda, S, Cronk, D, Long, A, Kane, E, Hossain, M, Needs, C, Edwards, Duncan, Jones, A, Zaman, M. Justin, James Brimicombe, Zaman, Justin, Brown, K, Pilling, Mark, Angeleri-Rand, E, Basuita, A, Gayton, E, Hernandez-Diaz, B, Taylor, CJ, F.D. Richard Hobbs, Hobbs, FD Richard, Chakravorty, M, Gaw, M, Brown, A, Forsyth, Faye, Mant, Jonathan, Ayerst, R, Cheriyan, J, Thorley, N, Knox, K, Papworth, H, Zaman, MJ, Hobbs, FDR, Wooding, N, MacDonald, S, Keast, C, Smith, J, M. Justin Zaman, Pilling, M, Dixon, S, Sowden, E, Joseph Cheriyan, Aziz, A, Wanninayake, S, Hobbs, F. D. Richard, Forsyth, F, Taylor, Clare, Rebekah Schiff, Swayze, H, Odone, J, Mark Pilling, Thomas, N, Faye Forsyth, Sharpley, J, Deaton, C, A'Court, C, Christi Deaton   +84 more
core   +3 more sources

Cardiometabolic HFpEF: mechanisms and therapies [PDF]

, 2021
Heart failure with preserved ejection fraction (HFpEF) accounts for at least half of all patients with heart failure (HF) and is projected to be the most common form of HF in the near feature.
Hill, J.A., Schiattarella, G.G.
core   +1 more source

Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

Background and Aims In the STEP-HFpEF trial program, treatment with semaglutide resulted in multiple beneficial effects in patients with obesity-related heart failure with preserved ejection fraction (HFpEF).
Mikhail N Kosiborod (9640584), Tuvia Ben-Gal (14600139), Rabea Asleh (8396478), Shachi Patel (427026), Sanjiv J Shah (5102324), Mette N Einfeldt (18568477), Khaja M Chinnakondepalli (18568474), Kavita Sharma (1951042), Subodh Verma (3398249), Barry A Borlaug (15192541), Thomas J Jensen (18568480), Melanie Davies (545715), Dalane W Kitzman (17025513), Javed Butler (174923), Mark C Petrie (10802097), Søren Rasmussen (3542885)   +15 more
core   +5 more sources

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches

Рациональная фармакотерапия в кардиологии, 2021
Heart failure with preserved ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Little progress has been in the treatment of this condition since its introduction some 30 years ago.
A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov   +9 more
doaj   +1 more source

Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review

, 2021
Heart failure with preserved ejection fraction (HFpEF) is problematic to treat, with guidelines for HFpEF management concentrated on treating prevalent comorbidities.
Clark, Hannah, Gow, Jeff, Rana, Rezwanul, Smart, Neil, van der Touw, Tom, Pearson, Melissa   +5 more
core   +1 more source

STEP-HFpEF: A Large Step for HFpEF. [PDF]

Journal of the American College of Cardiology
Contains fulltext : 307714.pdf (Publisher’s version ) (Open Access)
Kimmenade, R.R.J. van, Hassing, C.
openaire   +3 more sources

Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options

Медицинский вестник Юга России, 2021
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart ...
A. A. Borisov, A. D. Gvozdeva, F. T. Ageev   +2 more
doaj   +1 more source